Skip to main content
OpenTrials
Completed

NCT Number: NCT02957643

Substitution of the Normal Levels of Iron and Hemoglobin in Pregnant Women With Iron Supplement

The purpose of the study is to investigate the effectiveness of iron in the treatment of iron deficiency in pregnant 2nd and 3rd quarter. Every 30 days the investigators measure the hemoglobin, hematocrit and iron in serum and assess the course of treatment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Prevention of Anemia

Age range

18 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 1 / Phase 2

About this study

The purpose of the study is to investigate the effectiveness of iron in the treatment of iron deficiency in pregnant 2nd and 3rd quarter. Every 30 days the investigators measure the hemoglobin, hematocrit and iron in serum and assess the course of treatment

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age more or equal of 18 years
  • Registration consent
  • Have complete 12h week of pregnancy
  • Hemoglobin levels <10,5 ptl
  • Hematocrit < 32 %

Exclusion criteria

  • Age <18 years
  • Absent registration consent
  • Step of pregnancy less than 12 weeks
  • Coadministration formulations iron oral or parenterally
  • Background of liver kirrosis
  • Background of aimosidirosis
  • Background acquired or chronic aimatochromatosis
  • Aplastic , Hemolytic anemia and chronic diseases
  • Chronic pancreatitis
  • Subjective renal or/and liver disease
  • Hypothyroidism or yperthyreoeidismos

Treatment and study plan

Iron

Drug

oral treatment

Other names: oral iron

Primary outcomes

  1. Measured and reported effectiveness of iron in the treatment of iron deficiency in pregnant 2nd and 3rd quarter with questionnaire

    Time frame: up to 24 months

    Measured and reported effectiveness of iron in the treatment of iron deficiency in pregnant

Secondary outcomes

  1. adverse reactions

    Time frame: up to 24 months

    adverse reactions

Sponsors and collaborators

Lead sponsor

Hippocration General Hospital

Other

Registry information

Official study title

Treatment of Iron Defieciency Anemia

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Nov 8, 2016
Registry last updated
Jul 29, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.